Medmain Inc. is a company to develop and provide “PidPort”, a pathological AI analysis solution, with a corporate mission of "to create a world where medical services can be accessed with technology anywhere, anytime."
“PidPort” is a product that enables the presentation of highly accurate and rapid analysis results by pathology AI developed by deep learning and the online pathological diagnosis such as remote pathological diagnosis.
There is a worldwide shortage of "pathologists" who make diagnoses of patients by looking at their tissues and cells to determine whether there is cancer or not and decide the treatment plan, and this has led to serious delays in pathological diagnosis and large regional disparities.
With our product “PidPort”, we aim to solve this problem and create a world in which patients can receive a high-quality pathological diagnosis immediately wherever they are.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 東京都港区南青山2-10-11 A青山ビル２f, Ark Hills South Tower 16f,japan
- in****@****ain.com
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- medmain.net
- HQ
- 港区, 東京都
Medmain Inc. Questions
Medmain Inc.'s website is medmain.net
Medmain Inc.'s LinkedIn profile is https://jp.linkedin.com/company/medmain-inc
Medmain Inc. has
13 employees.
View email and phone details for 13
employees at Medmain Inc..
Medmain Inc.'s industry is
Software Development
Medmain Inc.'s top competitors are
Morus Inc.,
Newond,
I'mbesideyou Inc.,
Anique Inc.,
Eneye,
Alchemist Material Inc.,
Medteria Inc.,
Orange Inc.,
Sagri Co., Ltd,
Legalon Technologies.
Medmain Inc.'s support email address is info@medmain.com
Medmain Inc.'s categories are Software Development
Medmain Inc.'s founding year is 2018
